20.11.2018 | Webinar: The RELEVANCE of ion channel interplay – Voltage-activated channels in non-excitable cells

   SyncroPatch 384PE,      Patchliner,      Port-a-Patch Webinar

Date: November 20. 2018, 4:00 PM CET (11:00 AM EDT)

The Webinar focuses on the automated patch clamp assay development for the study of red blood cells in health and disease and the RELEVANCE project, an international consortium of 13 partners from academia, diagnostic labs, blood supply centers, and small companies that combines basic and translational research to improve prognostic, diagnostic and therapeutic approaches on red blood cell function in health and disease. To this end, Nanion contributes assays for the electrophysiological characterization of healthy and patient-derived red blood cells.

12.09.2018 | Webinar: CiPA study: Bridging ion channel and myocyte data

   CardioExcyte 96,      Patchliner and      SyncroPatch 384PE Webinar

Date: September 12, 4:00 PM CEST (10:00 AM EDT)

 Get up-to-date with the CiPA progress of the Myocyte and Ion Channel Work Goups:

• CiPA myocyte phase II validation study results: cross-site comparison using the CardioExcyte 96
• HTS Phase I study: an update on progress of the CiPA Ion Channel Work Stream using the SyncroPatch 384PE and Patchliner

08.05.2018 | Webinar: HTS Sodium Ion Channel Assays on the SyncroPatch 384PE

   SyncroPatch 384PE

Learn about Sodium Ion Channel Assays on the SyncroPatch 384PE. Our speakers will present assays on Na_V1.1, Na_V1.7, Na_V1.8 and Na_V1.9:

• Biophysical and Pharmacological Characterization of Voltage-Gated Na Channels Involved in Pain Pathways.
• Identifying Na_V1.1  Enhancers to Restore Inhibitory Interneuron Function in Dravet Syndrome and Alzheimer’s Disease.

03.11.2016 | External Webinar: Accelerating Ion Channel Characterization and New Drug Candidate Identification

   SyncroPatch 384PE

This webinar will show high-throughput functional annotation of human ion channel variants associated with excitation disorders will be described along with use of the Syncropatch 384PE to measure subtype selective activation of K_V7 potassium channels as well as inhibition of voltage gated sodium channels like Na_V1.7, Na_V1.1, and Na_V1.5.
Organisation: Icagen Inc.

07.06.2016 | External Webinar: A new analysis capability to improve assessment of cardiac liability in high throughput electrophysiology

   SyncroPatch 384PE

AstraZeneca has implemented the Nanion SyncroPatch 384PE electrophysiology platform. This webinar will show how AstraZeneca and Genedata developed a processing and analysis pipeline for the complex data, reading binary raw data directly from the instrument into Genedata Screener.
Organisation: Genedata AG.

28.07.2015 | Webinar: High Throughput and High Fidelity: Automated Patch Clamp in Screening and Research

   SyncroPatch 384PE and      Patchliner 

The webinar covers the use of the Patchliner and the SyncroPatch 384/768PE for characterization of ion channels and screening of ion channel active compounds.

24.10.2013 | Webinar: SyncroPatch 384PE - the PatchEngine. Superior Ion Channel Drug Screening

   SyncroPatch 384PE

The Webinar covers the introduction of the SyncroPatch 384PE and its features.

07.03.2013 | Webinar: Top gear ion channel screening

   SyncroPatch 96 (a predecessor model of SyncroPatch 384PE)

This Webinar covers the general setup of the and features of this automated patch clamp device.

20.11.2018 | Webinar: The RELEVANCE of ion channel interplay – Voltage-activated channels in non-excitable cells

   SyncroPatch 384PE,      Patchliner,      Port-a-Patch Webinar

Date: November 20. 2018, 4:00 PM CET (11:00 AM EDT)

The Webinar focuses on the automated patch clamp assay development for the study of red blood cells in health and disease and the RELEVANCE project, an international consortium of 13 partners from academia, diagnostic labs, blood supply centers, and small companies that combines basic and translational research to improve prognostic, diagnostic and therapeutic approaches on red blood cell function in health and disease. To this end, Nanion contributes assays for the electrophysiological characterization of healthy and patient-derived red blood cells.

12.09.2018 | Webinar: CiPA study: Bridging ion channel and myocyte data

   CardioExcyte 96,      Patchliner and      SyncroPatch 384PE Webinar

Date: September 12, 4:00 PM CEST (10:00 AM EDT)

 Get up-to-date with the CiPA progress of the Myocyte and Ion Channel Work Goups:

• CiPA myocyte phase II validation study results: cross-site comparison using the CardioExcyte 96
• HTS Phase I study: an update on progress of the CiPA Ion Channel Work Stream using the SyncroPatch 384PE and Patchliner

27.06.2017 | Webinar: New Dynamics in Automated Patch Clamp

   Patchliner

This webinar shows new applications on dynamic patch clamp of iPSC-derived cardiomyocytes and introduces an assay on K_Ca3.1 expressed in erythrocytes

28.07.2015 | Webinar: High Throughput and High Fidelity: Automated Patch Clamp in Screening and Research

   SyncroPatch 384PE and      Patchliner 

The webinar covers the use of the Patchliner and the SyncroPatch 384/768PE for characterization of ion channels and screening of ion channel active compounds.

11.05.2013 | Webinar: Patchliner - unlimited experimental freedom

   Patchliner   Patchliner - unlimited experimental freedom

This Webinar covers the features of the Patchlliner, including the "minimized cell usage" for expensive cells.

20.11.2018 | Webinar: The RELEVANCE of ion channel interplay – Voltage-activated channels in non-excitable cells

   SyncroPatch 384PE,      Patchliner,      Port-a-Patch Webinar

Date: November 20. 2018, 4:00 PM CET (11:00 AM EDT)

The Webinar focuses on the automated patch clamp assay development for the study of red blood cells in health and disease and the RELEVANCE project, an international consortium of 13 partners from academia, diagnostic labs, blood supply centers, and small companies that combines basic and translational research to improve prognostic, diagnostic and therapeutic approaches on red blood cell function in health and disease. To this end, Nanion contributes assays for the electrophysiological characterization of healthy and patient-derived red blood cells.

07.10.2015 | Webinar: Patch Clamp Made Easy, Fast Track to Excellence

   Port-a-Patch

This webinar shows applications that go way beyond possibilities of conventional patch-clamping, where the Port-a-Patch facilitates completely novel scientific directions.

12.09.2018 | Webinar: CiPA study: Bridging ion channel and myocyte data

   CardioExcyte 96,      Patchliner and      SyncroPatch 384PE Webinar

Date: September 12, 4:00 PM CEST (10:00 AM EDT)

 Get up-to-date with the CiPA progress of the Myocyte and Ion Channel Work Goups:

• CiPA myocyte phase II validation study results: cross-site comparison using the CardioExcyte 96
• HTS Phase I study: an update on progress of the CiPA Ion Channel Work Stream using the SyncroPatch 384PE and Patchliner

28.04.2015 | Webinar: Excited About Contraction – Combining Contractility and Excitability Measurements in Cardiotoxicity Screening

   CardioExcyte 96

This Webinar covers the introduction of the CardioExcyte 96, a hybrid device for impedance- and MEA-type recordings from intact, beating networks of stem cell-derived cardiomyocytes.

28.06.2018 | Webinar: Artificial Lipid Bilayers in focus: Hand-held DNA-sequencing and biosensing with nanopores

    Orbit mini and      Orbit 16

Learn about single channel measurements in bilayer recording using the orbit instrument family

- Simplifying artificial bilayer experiments: Single-molecule experiments on micro-cavity arrays
- Hand-held DNA-sequencing and biosensing with nanopores 

27.01.2016 | Webinar: Instant bilayers - just add protein

   Orbit 16 and      Orbit Mini

This webinar covers the use of the lipid bilayer platforms from Nanion: the Orbit16 and the Orbit mini for characterization of membrane proteins like ion channels, bacterial porins and biological nanopores. Both bilayer systems support high quality low noise recordings, but differ in throughput capabilities and experimental features. The Orbit16, introduced in 2012 is a device for efficient formation of 16 lipid bilayers simultaneously, allowing for parallel bilayer-reconstitution of ion channels and nanopores.

30.01.2018 | Webinar: The SURFE²R Technology: Assays for Parmacological and Functional Characterization of Membrane Transporters

   SURFE²R 96SE and      SURFE²R N1

This webinar gives you an overview on the SURFE²R technology and its applications. Furthermore, we invited Dr. Thomas Licher (Sanofi Germany) as speaker, to present his work and experiences on the SURFE²R 96SE device.